Biosciences company cleans up at awards

Category：Company News Key Words：clean, Professional, Genesis Biosciences Time：2016-03-04 15:13

A UK-based biosciences company has been recognised as one of Europe’s leading microbial product developers, after emerging victorious at a number of prestigious awards.

Genesis Biosciences in Cardiff has had a string of triumphs this year after launching their Evogen microbial product range, Evogen Professional, and winning two awards for their innovation and scientific breakthroughs.

The company is said to have been the first to develop, manufacture and offer both microbial and antimicrobial products, and is currently the market leader in bacteria fermentation. Evogen Professional is a microbial, eco-benign range of high performance cleaning products for the facilities management sector.

Judges at the Awards described Evogen as an extremely exciting and innovative product, with massive potential. Primary Judge edie's 2015 Sustainability Leaders Awards and Head of Programme at RSA Great Recovery, Lucy Chamberlain said: “Evogen radically changes the way we think about cleaning; about the environment and about our responsibility to use a more effective, lower cost, ‘friendly’ alternative to chemical cleaners.”

In addition to being awarded an international award, Genesis Biosciences overcame stiff competition to be crowned Technology and Innovation Business of the Year 2015 at the inaugural Cardiff Business Awards, which was established to celebrate the entrepreneurial and innovative ventures leading the way within the Welsh capital city.

John Clark, MD for Genesis Biosciences, said: “Winning these awards is the culmination of extensive research into application-specific bacteria which has resulted in unrivalled results across a series of markets."

PREV：Long-standing partnership continues NEXT：Energy efficient hand dryer

A UK-based biosciences company has been recognised as one of Europe’s leading microbial product developers, after emerging victorious at a number of prestigious awards.   </p>
<section class="introduction" style="width: 485px;">
<section align="center">
<section id="PAJLST39" style="height: auto;">
<section id="PAJLST39_1">
<div><img title="(l-r) phil caunt and emma saunders" src="http://resource2.ultdb.net/res/org0011/Y2015/M12/201512100UK9.jpg" alt="" width="300" align="center" /></section>
</section>
</section>
<section id="XPAJLST39" class="XSub_List" style="height: auto; display: none;"> </section>
</section>
</section>
<section class="caption" style="display: none;"> </section>
<section style="margin-top: 25px;">
<p>Genesis Biosciences in Cardiff has had a string of triumphs this year after launching their Evogen microbial product range, Evogen Professional, and winning two awards for their innovation and scientific breakthroughs. </p>
<p>The company is said to have been the first to develop, manufacture and offer both microbial and antimicrobial products, and is currently the market leader in bacteria fermentation. Evogen Professional is a microbial, eco-benign range of high performance cleaning products for the facilities management sector.</p>
<p>Judges at the Awards described Evogen as an extremely exciting and innovative product, with massive potential. Primary Judge edie's 2015 Sustainability Leaders Awards and Head of Programme at RSA Great Recovery, Lucy Chamberlain said: “Evogen radically changes the way we think about cleaning; about the environment and about our responsibility to use a more effective, lower cost, ‘friendly’ alternative to chemical cleaners.”</p>
<p>In addition to being awarded an international award, Genesis Biosciences overcame stiff competition to be crowned Technology and Innovation Business of the Year 2015 at the inaugural Cardiff Business Awards, which was established to celebrate the entrepreneurial and innovative ventures leading the way within the Welsh capital city.</p>
<p>John Clark, MD for Genesis Biosciences, said: “Winning these awards is the culmination of extensive research into application-specific bacteria which has resulted in unrivalled results across a series of markets."</p>
</section>">